NEW YORK (GenomeWeb News) — Agilent Technologies today said fiscal fourth-quarter revenues increased 6 percent as R&D spending fell 8 percent and profit surged 508 percent.
 
Total receipts for the three months ended Sept. 30 increased to $1.33 billion from $1.25 billion year over year.
 
Revenue for the company’s Bio-Analytical Measurement segment rose 9 percent to $418 million.
 
R&D spending decreased to $155 million from $168 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.